{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:45:06Z","timestamp":1787021106879,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Rheumatol"],"DOI":"10.1186\/s41927-025-00576-x","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:13:00Z","timestamp":1761041580000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Relationship between anti-Epstein-Barr virus early antigen diffuse type and restricted type immunoglobulin G antibodies and disease activity and autoantibodies in rheumatoid arthritis: a retrospective observational study"],"prefix":"10.1186","volume":"9","author":[{"given":"Noboru","family":"Kitamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Nagasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumiko","family":"Akiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotake","family":"Inomata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"key":"576_CR1","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1093\/rheumatology\/keaa232","volume":"59","author":"LE Dedmon","year":"2020","unstructured":"Dedmon LE. The genetics of rheumatoid arthritis. Rheumatology (Oxford). 2020;59:2661\u201370.","journal-title":"Rheumatology (Oxford)"},{"key":"576_CR2","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1136\/ard.2008.096487","volume":"69","author":"D Sugiyama","year":"2010","unstructured":"Sugiyama D, Nishimura K, Tamaki K, Tsuji G, Nakazawa T, Morinobu A, et al. Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis. 2010;69:70\u201381.","journal-title":"Ann Rheum Dis"},{"key":"576_CR3","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1002\/art.27552","volume":"62","author":"N Wegner","year":"2010","unstructured":"Wegner N, Wait R, Sroka A, Eick S, Nguyen KA, Lundberg K, et al. Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and \u03b1-enolase: implications for autoimmunity in rheumatoid arthritis. Arthritis Rheum. 2010;62:2662\u201372.","journal-title":"Arthritis Rheum"},{"key":"576_CR4","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jbspin.2017.04.011","volume":"85","author":"N Balandraud","year":"2018","unstructured":"Balandraud N, Roudier J. Epstein-Barr virus and rheumatoid arthritis. Joint Bone Spine. 2018;85:165\u201370.","journal-title":"Joint Bone Spine"},{"key":"576_CR5","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1093\/intimm\/9.5.739","volume":"9","author":"M Takei","year":"1997","unstructured":"Takei M, Mitamura K, Fujiwara S, Horie T, Ryu J, Osaka S, et al. Detection of Epstein-Barr virus-encoded small RNA 1 and latent membrane protein 1 in synovial lining cells from rheumatoid arthritis patients. Int Immunol. 1997;9:739\u201343.","journal-title":"Int Immunol"},{"key":"576_CR6","doi-asserted-by":"publisher","first-page":"3694","DOI":"10.4049\/jimmunol.162.6.3694","volume":"162","author":"JW Edinger","year":"1999","unstructured":"Edinger JW, Bonneville M, Scotet E, Houssaint E, Schumacher HR, Posnett DN. EBV gene expression not altered in rheumatoid synovia despite the presence of EBV antigen-specific T cell clones. J Immunol. 1999;162:3694\u2013701.","journal-title":"J Immunol"},{"key":"576_CR7","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1002\/1529-0131(200006)43:6<1218::AID-ANR4>3.0.CO;2-2","volume":"43","author":"T Takeda","year":"2000","unstructured":"Takeda T, Mizugaki Y, Matsubara L, Imai S, Koike T, Takada K. Lytic Epstein-Barr virus infection in the synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum. 2000;43:1218\u201325.","journal-title":"Arthritis Rheum"},{"key":"576_CR8","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/modpathol.3800119","volume":"17","author":"Y Mehraein","year":"2004","unstructured":"Mehraein Y, Lennerz C, Ehlhardt S, Remberger K, Ojak A, Zang KD. Latent Epstein-Barr virus (EBV) infection and cytomegalovirus (CMV) infection in synovial tissue of autoimmune chronic arthritis determined by RNA- and DNA-in situ hybridization. Mod Pathol. 2004;17:781\u20139.","journal-title":"Mod Pathol"},{"key":"576_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.5501\/wjv.v1.i1.31","volume":"12","author":"M De Paschale","year":"2012","unstructured":"De Paschale M, Clerici P. Serological diagnosis of Epstein-Barr virus infection: problems and solutions. World J Virol. 2012;12:31\u201343.","journal-title":"World J Virol"},{"key":"576_CR10","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1002\/art.27580","volume":"62","author":"T Neogi","year":"2010","unstructured":"Neogi T, Aletaha D, Silman AJ, Naden RL, Felson DT, Aggarwal R, et al. The 2010 American College of Rheumatology\/European League Against Rheumatism classification criteria for rheumatoid arthritis: phase 2 methodological report. Arthritis Rheum. 2010;62:2582\u201391.","journal-title":"Arthritis Rheum"},{"key":"576_CR11","doi-asserted-by":"publisher","first-page":"4996","DOI":"10.1128\/JCM.42.11.4996-5000.2004","volume":"42","author":"JS Klutts","year":"2004","unstructured":"Klutts JS, Liao RA, Dunne WM Jr, Gronowski M. Evaluation of a multiplexed bead assay for assessment of Epstein-Barr virus Immunologic status. J Clin Microbiol. 2004;42:4996\u20135000.","journal-title":"J Clin Microbiol"},{"key":"576_CR12","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1128\/JCM.37.1.132-136.1999","volume":"37","author":"H Kimura","year":"1999","unstructured":"Kimura H, Morita M, Yabuta Y, Kuzushima K, Kato K, Kojima S, et al. Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. J Clin Microbiol. 1999;37:132\u20136.","journal-title":"J Clin Microbiol"},{"key":"576_CR13","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1084\/jem.147.4.1018","volume":"147","author":"MA Alspaugh","year":"1978","unstructured":"Alspaugh MA, Jensen FC, Rabin H, Tan EM. Lymphocytes transformed by Epstein-Barr virus. Induction of nuclear antigen reactive with antibody in rheumatoid arthritis. J Exp Med. 1978;147:1018\u201327.","journal-title":"J Exp Med"},{"key":"576_CR14","doi-asserted-by":"publisher","first-page":"7104","DOI":"10.1073\/pnas.80.23.7104","volume":"80","author":"PB Billings","year":"1983","unstructured":"Billings PB, Hoch SO, White PJ, Carson DA, Vaughan JH. Antibodies to the Epstein-Barr virus nuclear antigen and to rheumatoid arthritis nuclear antigen identify the same polypeptide. Proc Natl Acad Sci U S A. 1983;80:7104\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"576_CR15","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/j.1365-3083.1988.tb02359.x","volume":"27","author":"J Roudier","year":"1988","unstructured":"Roudier J, Rhodes G, Petersen J, Vaughan JH, Carson DA. The Epstein-Barr virus glycoprotein gp110, a molecular link between HLA DR4, HLA DR1, and rheumatoid arthritis. Scand J Immunol. 1988;27:367\u201371.","journal-title":"Scand J Immunol"},{"key":"576_CR16","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1002\/1529-0131(199907)42:7<1485::AID-ANR24>3.0.CO;2-7","volume":"42","author":"JG Saal","year":"1999","unstructured":"Saal JG, Krimmel M, Steidle M, Gerneth F, Wagner S, Fritz P, et al. Synovial Epstein-Barr virus infection increases the risk of rheumatoid arthritis in individuals with the shared HLA-DR4 epitope. Arthritis Rheum. 1999;42:1485\u201396.","journal-title":"Arthritis Rheum"},{"key":"576_CR17","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/345447a0","volume":"345","author":"R F\u00e5hraeus","year":"1990","unstructured":"F\u00e5hraeus R, Rymo L, Rhim JS, Klein G. Morphological transformation of human keratinocytes expressing the LMP gene of Epstein- Barr virus. Nature. 1990;345:447\u20139.","journal-title":"Nature"},{"key":"576_CR18","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.3390\/microorganisms11081958","volume":"11","author":"D Miljanovic","year":"2023","unstructured":"Miljanovic D, Cirkovic A, Jermic I, Basaric M, Lazarevic I, Grk M, et al. Markers of Epstein-Barr virus infection in association with the onset and poor control of rheumatoid arthritis: a prospective cohort study. Microorganisms. 2023;11:1958.","journal-title":"Microorganisms"},{"issue":"Suppl 1","key":"576_CR19","first-page":"S69","volume":"3","author":"S Sawada","year":"2004","unstructured":"Sawada S, Takei M. Possible involvement of Epstein-Barr virus and its regulatory gene in rheumatoid synovitis. Autoimmun Rev. 2004;3(Suppl 1):S69\u201371.","journal-title":"Autoimmun Rev"},{"key":"576_CR20","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1182\/blood-2009-09-238832","volume":"116","author":"AD Hislop","year":"2010","unstructured":"Hislop AD, Palendira U, Leese AM, Arkwright PD, Rohrlich PS, Tangye SG, et al. Impaired Epstein-Barr virus-specific CD8\u2009+\u2009T-cell function in X-linked lymphoproliferative disease is restricted to SLAM family-positive B-cell targets. Blood. 2010;116:3249\u201357.","journal-title":"Blood"},{"key":"576_CR21","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.autrev.2007.01.015","volume":"6","author":"S Sawada","year":"2007","unstructured":"Sawada S, Takei M, Ishiwata T. SAP discovery: the sword edges\u2013beneficial and harmful. Autoimmun Rev. 2007;6:444\u20139.","journal-title":"Autoimmun Rev"},{"key":"576_CR22","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/(SICI)1096-9071(200004)60:4<411::AID-JMV8>3.0.CO;2-8","volume":"60","author":"R Shinkura","year":"2000","unstructured":"Shinkura R, Yamamoto N, Koriyama C, Shinmura Y, Eizuru Y, Tokunaga M. Epstein-Barr virus-specific antibodies in Epstein-Barr virus-positive and -negative gastric carcinoma cases in Japan. J Med Virol. 2000;60:411\u20136.","journal-title":"J Med Virol"},{"key":"576_CR23","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1128\/CMR.00044-10","volume":"24","author":"OA Odumade","year":"2011","unstructured":"Odumade OA, Hogquist A, Henry HB Jr. Progress and problems in Understanding and managing primary Epstein-Barr virus infections. Clin Microbiol Rev. 2011;24:193\u2013209.","journal-title":"Clin Microbiol Rev"},{"key":"576_CR24","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1093\/intimm\/13.4.559","volume":"13","author":"M Takei","year":"2001","unstructured":"Takei M, Ishiwata T, Mitamura K, Fujiwara S, Sasaki K, Nishi T, et al. Decreased expression of signaling lymphocytic-activation molecule-associated protein (SAP) transcripts in T cells from patients with rheumatoid arthritis. Int Immunol. 2001;13:559\u201365.","journal-title":"Int Immunol"},{"key":"576_CR25","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1093\/infdis\/135.3.374","volume":"135","author":"CV Sumaya","year":"1977","unstructured":"Sumaya CV. Endogenous reactivation of Epstein-Barr virus infection. J Infect Dis. 1977;135:374\u20139.","journal-title":"J Infect Dis"},{"key":"576_CR26","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.peptides.2016.01.005","volume":"76","author":"NH Trier","year":"2016","unstructured":"Trier NH, Holm BE, Slot O, Locht H, Lindegaard H, Svendsen A, et al. Application of synthetic peptides for detection of anti-citrullinated peptide antibodies. Peptides. 2016;76:87\u201395.","journal-title":"Peptides"},{"key":"576_CR27","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.3389\/fmicb.2017.01853","volume":"8","author":"LI Sakkas","year":"2017","unstructured":"Sakkas LI, Daoussis D, Liossis SN, Bogdanos DP. The infectious basis of ACPA-positive rheumatoid arthritis. Front Microbiol. 2017;8:1853.","journal-title":"Front Microbiol"},{"issue":"10","key":"576_CR28","doi-asserted-by":"publisher","first-page":"e26630","DOI":"10.1371\/journal.pone.0026630","volume":"6","author":"Y Kuwana","year":"2011","unstructured":"Kuwana Y, Takei M, Yajima M, Imadome K, Inomata H, Shiozaki M, et al. Epstein-Barr virus induces erosive arthritis in humanized mice. PLoS ONE. 2011;6(10):e26630. https:\/\/doi.org\/10.1371\/journal.pone.0026630.","journal-title":"PLoS ONE"},{"issue":"4","key":"576_CR29","doi-asserted-by":"publisher","first-page":"e0249340","DOI":"10.1371\/journal.pone.0249340","volume":"16","author":"Y Nagasawa","year":"2021","unstructured":"Nagasawa Y, Takei M, Iwata M, Nagatsuka Y, Tsuzuki H, Imai K, et al. Human osteoclastogenesis in Epstein-Barr virus-induced erosive arthritis in humanized NOD\/Shi-scid\/IL-2R\u03b3null mice. PLoS ONE. 2021;16(4):e0249340. https:\/\/doi.org\/10.1371\/journal.pone.0249340.","journal-title":"PLoS ONE"},{"key":"576_CR30","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s12288-024-01792-0","volume":"41","author":"A Bahadir","year":"2024","unstructured":"Bahadir A, Tekin T, Aydin ZGG, Reis GP, Erduran E. Evaluation of clinical and hematological findings of patients with acute and reactivated EBV infection. Indian J Hematol Blood Trans. 2024;41:89\u201395.","journal-title":"Indian J Hematol Blood Trans"},{"key":"576_CR31","doi-asserted-by":"publisher","first-page":"31077","DOI":"10.18632\/oncotarget.25780","volume":"9","author":"E Omozawa","year":"2018","unstructured":"Omozawa E, Shibayama H, Takada H, Imadome K, Aoki S, Yoshimori M, et al. STAT3 is constitutively activated in chronic antive Epstein-Barr virus infection and can be a therapeutic target. Oncotarget. 2018;9:31077\u201389.","journal-title":"Oncotarget"}],"container-title":["BMC Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-025-00576-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41927-025-00576-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-025-00576-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:04:21Z","timestamp":1761087861000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcrheumatol.biomedcentral.com\/articles\/10.1186\/s41927-025-00576-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["576"],"URL":"https:\/\/doi.org\/10.1186\/s41927-025-00576-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5812683\/v1","asserted-by":"object"}]},"ISSN":["2520-1026"],"issn-type":[{"value":"2520-1026","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"12 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Nihon University School of Medicine (approval number: RK-220712-5) and conducted in accordance with the principles of the Declaration of Helsinki. In addition, this study was a retrospective observational study based on medical record review, and because our hospital obtains comprehensive consent at the time of the first consultation, we did not obtain individual consent to participate this time.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"123"}}